skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Viral inhibitory nucleotide sequences and vaccines

Patent ·
OSTI ID:1771553

The invention relates to inhibitory nucleotide signal sequences or “INS” sequences in the genomes of lentiviruses. In particular the invention relates to the AGG motif present in all viral genomes. The AGG motif may have an inhibitory effect on a virus, for example by reducing the levels of, or maintaining low steady-state levels of, viral RNAs in host cells, and inducing and/or maintaining in viral latency. In one aspect, the invention provides vaccines that contain, or are produced from, viral nucleic acids in which the AGG sequences have been mutated. In another aspect, the invention provides methods and compositions for affecting the function of the AGG motif, and methods for identifying other INS sequences in viral genomes.

Research Organization:
Institute for Advanced Study, Princeton, NJ (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
FG02-90ER40542
Assignee:
Institute for Advanced Study (Princeton, NJ)
Patent Number(s):
10,815,277
Application Number:
15/228,451
OSTI ID:
1771553
Resource Relation:
Patent File Date: 08/04/2016
Country of Publication:
United States
Language:
English

References (40)

Site-directed mutagenesis by overlap extension using the polymerase chain reaction journal April 1989
Informatics for Unveiling Hidden Genome Signatures journal April 2003
The relationship between palindrome avoidance and intragenic codon usage variations: a Monte Carlo study journal April 2004
Homology journal May 2000
Inhibition of restriction endonuclease Nel I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis journal January 1986
Alignment-free sequence comparison--a review journal March 2003
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions journal January 1988
RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons journal July 2004
Suppression of HIV replication by dominant negative mutants of HIV-1 (review). journal September 1998
Concerted Action of Multiple cis-Acting Sequences Is Required for Rev Dependence of Late Human Immunodeficiency Virus Type 1 Gene Expression journal November 2000
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension journal April 1989
Computational dna Sequence Analysis journal October 1994
Environmental Genome Shotgun Sequencing of the Sargasso Sea journal April 2004
Tissue-specific codon usage and the expression of human genes journal August 2004
Orthology: Secret life of genes journal February 2002
Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons journal January 1989
Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals journal March 2004
Coreceptor Tropism Can Be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein journal March 2008
Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes journal December 2002
Method of eliminating inhibitory/instability regions of mRNA patent September 2004
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine journal May 2006
Rapid and efficient site-specific mutagenesis without phenotypic selection. journal January 1985
Site-directed mutagenesis of virtually any plasmid by eliminating a unique site journal January 1992
A Recoding Method to Improve the Humoral Immune Response to an HIV DNA Vaccine journal September 2008
Viral vaccine composition, process, and methods of use patent-application May 2003
What are DNA sequence motifs? journal April 2006
Efficient site directed in vitro mutagenesis using ampicillin selection journal January 1990
A Single-Stranded DNA Binding Site in the Human A 1 Adenosine Receptor Gene Promoter journal January 1998
Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein journal May 2003
Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag Gene journal March 2000
Similarities and dissimilarities of phage genomes. journal June 1996
The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA journal January 1985
On Information and Sufficiency journal March 1951
Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins patent October 2005
Adenovirus carrying gag gene HIV vaccine patent September 2004
Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes journal February 1981
Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein journal October 1999
Highly expressible genes patent May 2004
Genome-Scale Compositional Comparisons in Eukaryotes journal April 2001
Isochores and tissue-specificity journal September 2003

Similar Records

Related Subjects